Acetylation of KLF5 maintains EMT and tumorigenicity to cause chemoresistant bone metastasis in prostate cancer
Baotong Zhang(Emory University), Jin‐Tang Dong(Southern University of Science and Technology)
Cited by 161
Related Papers
SnoRNA U50 is a candidate tumor-suppressor gene at 6q14.3 with a mutation associated with clinically significant prostate cancer
|Human Molecular Genetics|2007|196
TGF-β causes Docetaxel resistance in Prostate Cancer via the induction of Bcl-2 by acetylated KLF5 and Protein Stabilization
|Theranostics|2020|64
ZFHX3 is indispensable for ERβ to inhibit cell proliferation via MYC downregulation in prostate cancer cells
|Oncogenesis|2019|57
Interruption of KLF5 acetylation converts its function from tumor suppressor to tumor promoter in prostate cancer cells
|International Journal of Cancer|2014|50
Klf5 acetylation regulates luminal differentiation of basal progenitors in prostate development and regeneration
|Nature Communications|2020|43